SCHEMBL7003316

SCHEMBL7003316

CCN(CC)CCNC(=O)c1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 9/20 0.61
KDR P35968 2/20 0.52
CDK1 P06493 1/20 0.49
CDK2 P24941 1/20 0.49
NAMPT P43490 1/20 0.48
SGK1 O00141 2/20 0.47
AKT1 P31749 2/20 0.47
AKT2 P31751 2/20 0.47
AKT3 Q9Y243 2/20 0.47
CHEK2 O96017 1/20 0.47
PRKCG P05129 1/20 0.47
MARK2 Q7KZI7 1/20 0.47
LMNA P02545 2/20 0.46
SLC22A2 O15244 1/20 0.46
SLC22A1 O15245 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
ACHE P22303 1/20 0.46
MAPK1 P28482 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7095328 0.99 CHEK1 (0.60) CHEK1KDRCDK1CDK2NAMPT
SCHEMBL7094461 0.94 CHEK1 (0.56) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7092549 0.93 CHEK1 (0.60) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7696820 0.90 CHEK1 (0.73) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7089380 0.88 CHEK1 (0.56) CHEK1KDRCDK1CDK2SGK1
SCHEMBL6998055 0.88 CHEK1 (0.60) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7704746 0.87 CHEK1 (0.64) CHEK1SGK1AKT1AKT2AKT3
SCHEMBL7095511 0.87 CHEK1 (0.59) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7000847 0.87 CHEK1 (0.60) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7696882 0.87 CHEK1 (0.51) CHEK1KDRCDK1CDK2NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed